z-logo
open-access-imgOpen Access
Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma
Author(s) -
Sara Galimberti
Publication year - 2010
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmr.s7960
Subject(s) - temsirolimus , mantle cell lymphoma , refractory (planetary science) , medicine , mantle (geology) , lymphoma , cancer research , oncology , geology , geochemistry , discovery and development of mtor inhibitors , biology , astrobiology , apoptosis , biochemistry , protein kinase b

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom